gimli

SUDEEPPHRM stock AI analysis

SUDEEPPHRM Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

SUDEEP PHARMA LIMITED is a small-cap stock in Chemicals. This Gimli page shows the latest available SUDEEPPHRM price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive SUDEEPPHRM stock page

Price

₹1,155.00

1W return

-4.82%

1M return

+4.61%

3M return

+35.48%

6M return

+85.69%

1Y return

n/a

Market cap

₹13,045.56 cr

73.87

14.53

ROE

+41.60%

ROCE

+34.65%

RSI

50.73

Turnover

₹25.09 cr

Why it can matter in screens

Momentum: SUDEEPPHRM is above 50DMA, below 200DMA; RSI is 50.73.
Returns: 1D +4.49%, 1W -4.82%, 1M +4.61%, 3M +35.48%, 1Y n/a.
Trend levels: 52W high ₹1,378.00, 52W low ₹721.10, off high -16.18%.
Liquidity: latest turnover is ₹25.09 cr; volume vs 20D is +0.83%.
Valuation/profitability: PE 73.87, PB 14.53, ROE +41.60%, ROCE +34.65%.
Growth: 3Y sales CAGR -4.00%, 3Y profit CAGR +19.95%.

Quick Answers

What is the latest SUDEEPPHRM stock price?

The latest stored price for SUDEEPPHRM is Rs 1,155.00 as of 2026-09-18.

Is SUDEEPPHRM above its 50DMA and 200DMA?

SUDEEPPHRM is above 50DMA, below 200DMA. The latest 50DMA is 1,043.83 and the latest 200DMA is n/a.

What are SUDEEPPHRM PE, ROE and ROCE?

SUDEEPPHRM has PE 73.87, ROE +41.60%, and ROCE +34.65% in Gimli's latest available snapshot.

How has SUDEEPPHRM performed recently?

SUDEEPPHRM has returned +4.61% over 1 month, +35.48% over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-06-30	115.48 cr	49.00 cr	33.83 cr	3.59
2026-03-31	188.76 cr	69.02 cr	48.54 cr	nan
2025-12-31	172.34 cr	66.81 cr	47.46 cr	4.29
2025-09-30	172.84 cr	65.63 cr	46.78 cr	4.20
2025-06-30	124.19 cr	48.53 cr	30.81 cr	2.73
2025-03-31	152.96 cr	61.35 cr	44.15 cr	nan
2024-12-31	115.54 cr	41.73 cr	28.71 cr	2.54

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	377.01 cr	158.27 cr	107.58 cr	9.65
2025-03-31	497.41 cr	198.09 cr	138.69 cr	12.28
2024-03-31	454.67 cr	186.90 cr	133.19 cr	11.79
2023-03-31	426.17 cr	97.30 cr	62.32 cr	5.52
2022-03-31	353.02 cr	76.22 cr	52.31 cr	371.20

Balance sheet

Period	Assets	Cash	Debt	Equity
2025-03-31	717.17 cr	36.81 cr	137.55 cr	493.09 cr
2024-03-31	513.87 cr	13.98 cr	78.08 cr	356.03 cr
2023-03-31	420.11 cr	10.30 cr	83.08 cr	223.28 cr

Cash flow

Period	OCF	FCF	Cash change
2025-03-31	48.73 cr	-15.51 cr	n/a
2024-03-31	65.69 cr	13.22 cr	n/a
2023-03-31	48.40 cr	1.24 cr	n/a

Shareholding Trend

Period	Promoter	FII/FPI	DII	MF	Retail	Pledge
2026-06-30	+76.15%	+1.81%	+15.65%	+5.47%	+6.39%	+0.00%
2026-03-31	+76.15%	+1.55%	+18.11%	+6.19%	+4.18%	+0.00%
2025-12-31	+76.15%	+1.67%	+17.60%	+5.67%	+4.58%	+0.00%
2025-11-27	+76.15%	+1.54%	+14.76%	+3.44%	+7.54%	+0.00%

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SOLARINDS	SOLAR INDUSTRIES (I) LTD	167,904.38 cr	84.314744	+35.93%	+26.94%
PIDILITIND	PIDILITE INDUSTRIES LTD	160,004.45 cr	60.281452	+25.27%	+2.95%
SRF	SRF LTD	74,457.19 cr	34.443333	+16.21%	-14.49%
COROMANDEL	COROMANDEL INTERNTL. LTD	58,928.92 cr	32.377284	+14.95%	-13.24%
LINDEINDIA	LINDE INDIA LIMITED	53,230.13 cr	96.965414	+13.58%	-3.17%
FLUOROCHEM	GUJARAT FLUOROCHEM LTD	50,384.90 cr	87.171106	+7.60%	+23.51%
FACT	FACT LTD	49,449.24 cr	-1248.718238	-2.91%	-22.73%
UPL	UPL LIMITED	48,961.82 cr	23.550659	+5.26%	-17.02%

Try these prompts

Analyze SUDEEP PHARMA with valuation, momentum and industry peers
Compare SUDEEPPHRM with other Chemicals stocks
Show small-cap stocks in Chemicals above 50DMA with positive 1M return
Find Chemicals stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-09-18. Not investment advice.